← All trials
NCT06076681
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 27, 2021
- Primary completion
- Jan 6, 2022
- Completion date
- Jan 6, 2022
- First posted
- Oct 11, 2023
- Last posted
- Nov 22, 2023
- Enrollment
- 40
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- TenNor Therapeutics LtdLead sponsor
- TenNor Therapeutics LtdStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.